AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2004
Feb 25, 2004
34117_dirs_2004-02-25_c015c960-0767-4e82-bd7c-4b0c780878d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2004-02-23
Reporting Person: KRUSOS DENIS A (Director, Chairman of the Board and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-02-23 | Employee Stock Option | $0.43 | A | 500000 | Acquired | 2014-02-22 | Common Stock (500000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the CopyTele, Inc. 2003 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6